Join an

Hidradenitis Suppurativa (HS)
Clinical Study
in Birmingham

Your Hidradenitis Suppurativa (HS) shouldn't define you.

Now you have the opportunity to join a clinical research study exploring possible new treatment options.

You could be eligible for the Step-Up HS Research Study if you:
  • Are aged 12 or above
  • Have been living with an HS diagnosis for a minimum of 6 months
  • Haven’t experienced significant relief from a prior HS treatment

If you’re interested in joining, the study’s medical team will go over more specific requirements with you.

Those who qualify will get all study-related medications (either the drug being tested or a placebo) and healthcare for free. You will also get paid for travel and other expenses.

Receive $100 per visit
- up to $1,900 for participating in this critical study.


About Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa (HS) also known as Acne Inversa is a skin issue that leads to sore lumps on your skin. These lumps commonly show up in areas like your armpits, groin, butt, and chest. They can hurt, leave scars, leak fluid, and sometimes even smell bad. Most people start experiencing these symptoms between their teenage years and age 40. It’s estimated that up to 4% of people around the world have HS.

How Do I Sign Up?

Joining one of our FDA-governed clinical studies is simple and straightforward.

We never request any  proof of insurance or verification of citizenship status.

Here is all that’s required:

1. Complete Submission Form

You are asked to answer
only a few elementary

2. Pre-Qualify by Phone

One of our recruiters will briefly interview you about your skin condition.

3. Visit Our Office

We will schedule an appointment
for you to finalize your

4. Join Your Trial Group

If you qualify, you will participate
with others in a vital
clinical study.

5. Collect Your Money

As a study volunteer,
you will receive guaranteed compensation.

About the Step-Up HS Research Study

The Step-Up HS Research Study is a clinical research study designed to evaluate the safety and efficacy of an investigational drug compared to a placebo in reducing symptoms and improving the quality of life for participants living with HS. Participants will receive either the investigational drug or a placebo (something that looks like the investigational drug but has no effect on the body), both administered orally (by mouth).

Cahaba Clinical Research - Team of doctors looking at report